4th Quarter - Amendment
BGR GOVERNMENT AFFAIRS for AMGEN INC.
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (No Activity) | Nov 17, 2016 | — | Replaced |
| 4th Quarter - Amendment (this page) | Jan 23, 2017 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Provide advice and strategic counsel with regard to regulations that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, 340b, FDA regulatory issues, and corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOYER | See prior filing |
| BRENT ALAN DEL MONTE | See prior filing |
| RYAN LONG | See prior filing |
| ROBERT WOOD | See prior filing |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.